Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma

Published:2024-09 Issue:9 Volume:30 Page:885.e1-885.e11
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Ray Markqayne D.,Kanters Steve^ORCID,Beygi Sara,Best Timothy,Wulff Jacob,Limbrick-Oldfield Eve,Patel Anik R.,Oluwole Olalekan O.^ORCID

Funder

Kite Pharma Inc

Publisher

Elsevier BV

Reference28 articles.

1. How I treat indolent lymphoma;Gribben;Blood,2007

2. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011;Al-Hamadani;Am J Hematol,2015

3. The evolving role of targeted biological agents in the management of indolent B-cell lymphomas;Wang;Ther Adv Hematol,2017

4. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups;Batlevi;Blood Cancer J,2020

5. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibody Therapies in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP